Journal article
Managing haematology and oncology patients during the COVID-19 pandemic: interim consensus guidance
R Weinkove, ZK McQuilten, J Adler, MR Agar, E Blyth, AC Cheng, R Conyers, GM Haeusler, C Hardie, C Jackson, SW Lane, T Middlemiss, P Mollee, SP Mulligan, D Ritchie, M Ruka, B Solomon, J Szer, KA Thursky, EM Wood Show all
Medical Journal of Australia | WILEY | Published : 2020
DOI: 10.5694/mja2.50607
Abstract
Introduction: A pandemic coronavirus, SARS-CoV-2, causes COVID-19, a potentially life-threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID-19. Community transmission of COVID-19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic. Main recommendations: During the COVID-19 pandemic:. In patients with cancer with fever and/or respiratory symptoms, consider causes in addition to COVID-19, including other infections and therapy-related pneumoniti..
View full abstract